| | |
| Clinical data | |
|---|---|
| Other names | 2,3,6-TMPEA; TMPEA-5; 2C-TMA-5 |
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C11H17NO3 |
| Molar mass | 211.261 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2,3,6-Trimethoxyphenethylamine (2,3,6-TMPEA), also known as TMPEA-5 or as 2C-TMA-5, is a chemical compound of the phenethylamine family related to mescaline (3,4,5-trimethoxyphenethylamine). [1] [2] [3] [4] It is one of the possible positional isomers of trimethoxyphenethylamine and is a positional isomer of mescaline. [1] [2] [3] [4] According to Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved), 2,3,6-TMPEA is not known to have ever been tested in humans. [1] [3] It is either a competitive substrate or inhibitor of monoamine oxidase (MAO). [3] [1] [2] The chemical synthesis of 2,3,6-TMPEA has been described. [4] 2,3,6-TMPEA was first described in the scientific literature by J. R. Merchant and A. J. Mountwala in 1958. [2] As a positional isomer of mescaline, it is a Schedule I controlled substance in the United States. [2]